Show simple item record

dc.contributor.authorZhao, Sizheng Steven
dc.contributor.authorJones, Gareth T
dc.contributor.authorHughes, David M
dc.contributor.authorMoots, Robert J
dc.contributor.authorGoodson, Nicola J
dc.date.accessioned2021-12-10T13:48:01Z
dc.date.available2021-12-10T13:48:01Z
dc.date.issued2021-12
dc.identifier.citationZhao , S S , Jones , G T , Hughes , D M , Moots , R J & Goodson , N J 2021 , ' Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis ' , Rheumatology , vol. 60 , no. 12 , pp. 5734–5742 . https://doi.org/10.1093/rheumatology/keab242en
dc.identifier.issn1462-0324
dc.identifier.otherPURE: 191493978
dc.identifier.otherPURE UUID: 4eed212b-cfff-4d85-a42d-243e8ebc6170
dc.identifier.otherPubMed: 33713118
dc.identifier.otherORCID: /0000-0003-0016-7591/work/93483281
dc.identifier.otherScopus: 85122546134
dc.identifier.urihttps://hdl.handle.net/2164/17659
dc.descriptionAcknowledgment We are grateful to Professor Gary Macfarlane for commenting on the manuscript. We are grateful to the staff of the BSRBR-AS register and to the recruiting staff at the clinical centres, details of which are available at: www.abdn.ac.uk/bsrbr-as. We also thank Dr Lewis Carpenter for suggesting splines for modelling time. Contribution: SSZ analysed the data and wrote the manuscript with significant input from all co- authors. GTJ is the Deputy Chief Investigator on BSRBR-AS and designed the study and oversaw its conduct. In the current project they discussed results and provided input into drafts of the manuscript. Funding: The BSRBR-AS is funded by the British Society for Rheumatology (BSR) who have received funding for this from Pfizer, AbbVie and UCB. These companies receive advance copies of manuscripts for comments. They have no input in determining the topics for analysis or work involved in undertaking it.en
dc.format.extent9
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.rights© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.comen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectaxial spondyloarthritisen
dc.subjectdepressionen
dc.subjectmental healthen
dc.subjectanxietyen
dc.subjecttreatment responseen
dc.subjectR Medicineen
dc.subjectOtheren
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleDepression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1093/rheumatology/keab242
dc.identifier.vol60en
dc.identifier.iss12en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record